Continuous PEGasparaginase dosing reduces hypersensitivity reactions in pediatric ALL: a Dutch Childhood Oncology Group ALL11 randomized trial
Author(s):
Sluis, I.M. van der; Brigitha, L.J.; Fiocco, M.; Groot-Kruseman, H.A. de; Bierings, M.; Bos, C. van den; Haas, V. de; Hoogerbrugge, P.M.; Tissing, W.J.E.; Veening, M.A.; Pieters, R.
Published
2024
Publication type
Article / Letter to editor
Date issued
2024-05-10
Language
English
Is part of
Journal of Clinical Oncology (2024), Vol. 42, no. 14, p. 1676-1686
